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During development, two cell types born from closely
related progenitor pools often express identical tran-
scriptional regulators despite their completely distinct
characteristics.Thisphenomenon implies theneed for
amechanism that operates to segregate the identities
of the two cell types throughout differentiation after
initial fate commitment. To understand this mecha-
nism, we investigated the fate specification of spinal
V2a interneurons, which share important develop-
mental genes with motor neurons (MNs). We demon-
strate that the paired homeodomain factor Chx10
functions as a critical determinant for V2a fate and is
required to consolidate V2a identity in postmitotic
neurons. Chx10 actively promotes V2a fate, down-
stream of the LIM-homeodomain factor Lhx3, while
concomitantly suppressing the MN developmental
program by preventing the MN-specific transcription
complex from binding and activating MN genes. This
dual activity enables Chx10 to effectively separate
the V2a and MN pathways. Our study uncovers a
widely applicable gene regulatory principle for segre-
gating related cell fates.
INTRODUCTION
During embryonic organogenesis, many cell types are born in a
spatially and temporally controlled manner to form a functional
tissue. One of the most fundamental questions in developmental
biology is how closely related cell types are produced from
similar progenitors and yet acquire and maintain completely
distinct cell identities during later stages of organogenesis.
This relatively poorly understood process involves intricate
gene regulatory networks that operate during sequential steps
of cell fate commitment, specification, and differentiation.
The gene regulatory networks for motor neurons (MNs) and
V2a interneurons (V2aINs) provide an ideal platform to address
this topic. The morphogen Sonic hedgehog (shh) is secreted
from the notochord and floor plate and patterns neuroepithelial
cells along the dorso-ventral axis, leading to the formation of1642 Cell Reports 16, 1642–1652, August 9, 2016 ª 2016 The Author
This is an open access article under the CC BY-NC-ND license (http://the two neighboring progenitor domains, the pMN and p2 do-
mains (Figure 1A) (Catela et al., 2015; Lee and Pfaff, 2001). Pro-
genitor cells in the pMN and p2 domains produce MNs and
V2aINs, respectively. While pMN cells upregulate the LIM-home-
odomain (HD) transcription factors Isl1 and Lhx3 right before dif-
ferentiation toMNs, p2 cells upregulate Lhx3, but not Isl1, shortly
before cell-cycle exit (Figure 1A) (Ericson et al., 1992; Pfaff et al.,
1996; Sharma et al., 1998; Tsuchida et al., 1994). Isl1 and Lhx3
form a hexameric complex with a self-dimerizing cofactor NLI,
herein referred to as the Isl1-Lhx3-complex (also known as the
MN-hexamer; Figure 1A) (Lee et al., 2008; Lee and Pfaff, 2003;
Seo et al., 2015; Thaler et al., 2002). The Isl1-Lhx3-complex
directly controls a wide range of MN genes and plays crucial
roles in the fate specification of MNs (Cho et al., 2014; Lee
et al., 2004, 2008, 2012, 2013; Lee and Pfaff, 2003; Mazzoni
et al., 2013; Thaler et al., 2002; Thiebes et al., 2015). The misex-
pression of Lhx3 alone drives formation of ectopic V2aINs
marked by Chx10 in the developing spinal cord (Tanabe et al.,
1998; Thaler et al., 2002). Lhx3 also binds to NLI and forms a
tetrameric complex herein referred to as Lhx3-complex (also
known as the V2-tetramer; Figure 1A) (Joshi et al., 2009; Thaler
et al., 2002). It has remained unclear whether the Lhx3-complex
directly induces the expression of an array of V2aIN genes, simi-
larly to the Isl1-Lhx3-complex, or whether it indirectly triggers
V2aIN fate by upregulating other transcription factors that serve
as its downstream effectors to induce V2a identity. The segrega-
tion of pMN and p2 domains is initiated by the cross-repressive
actions of two transcription factors, Olig2 and Irx3, in the progen-
itor cells (Lee and Pfaff, 2001; Lu et al., 2002; Novitch et al., 2001;
Zhou and Anderson, 2002). Interestingly, pMN cells and
newborn MNs maintain cell fate plasticity and can switch their
fate into V2aINs when the MN pathway is dysregulated (Arber
et al., 1999; Lee et al., 2008; Lu et al., 2002; Song et al., 2009;
Thaler et al., 1999; Zhou and Anderson, 2002). These results
strongly suggest that the mechanisms that separate MN and
V2aIN identities continue to operate even after the progenitor
cells are committed to MN or V2aIN fate. However, the precise
regulatory mechanisms that consolidate V2aIN fate after cell-cy-
cle exit have yet to be clarified.
While Lhx3 triggers the V2aIN fate specification, it is also ex-
pressed in MNs (Sharma et al., 1998; Tsuchida et al., 1994),
thus warranting additional mechanisms to block erroneous acti-
vation of MN genes in differentiating V2aINs. It is possible thats.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Chx10 Is a Critical Downstream
Effector of Lhx3 in Promoting V2aIN Fate
(A) Illustration of the developing spinal cord
showing the specification of V2aINs and MNs from
the p2 and pMN progenitor domains, respectively,
in response to graded Shh signaling from the floor
plate. The Lhx3-complex is needed to drive V2aIN
fate, whereas the Isl1-Lhx3-complex triggers the
expression of MN genes (hexamer response
element, HxRE and tetramer response element,
TeRE).
(B) Illustration of the shRNA expression plasmid,
which encodes both shRNA and GFP expression
cassettes. The expression of the shRNA sequence
designed against Chx10 30 UTR (sh-Chx10) is
driven by the U6 promoter (U6p), while the
expression of GFP is driven by the EF1 promoter
(EF1p). Transverse sections of chick spinal cord
3 days after co-electroporation with Lhx3 together
with sh-vector or sh-Chx10 are shown. The GFP
marks the electroporated cells. Immunostaining
with Chx10 and Sox14 antibodies and in situ hy-
bridizations for Shox2 and VGluT2 mRNAs reveal
that Lhx3 drives ectopic expression of V2aINs
markers in the dorsal spinal cord (brackets). Co-
electroporation of sh-Chx10 with Lhx3 prevents
Lhx3 from inducing ectopic expression of V2aINs
markers (electroporated side of the spinal cord, +).
(C) Quantification of the changes in the number of
Chx10+ and Sox14+ cells in chick spinal cords
following the electroporation of Lhx3+sh-vector
(dark blue) or Lhx3+sh-Chx10 (light blue). Percent
changes of total Chx10+ cells (left graph) or Sox14+
cells (right graph) in the electroporated (+) side over
control side are presented. The zero means the
equal number of Chx10+ or Sox14+ cells between
the electroporated and control sides. The error
bars represent the SEM. The statistics represent the comparison to unelectroporated control sides (***p < 0.005; *p < 0.05; non-significant, ns; and n R 6
embryos).
(D) Model of the gene regulatory pathway of V2aIN development involving Lhx3 and Chx10. The upregulation of Chx10 is necessary for Lhx3 to induce V2aIN fate.Lhx3 induces the expression of other effector transcription fac-
tors only in V2aINs, rather than directly upregulating the expres-
sion of V2aIN genes. Those V2a-specific transcription factors
may then activate the expression of V2aIN genes. One such
candidate is Chx10 (Vsx2), a paired HD transcription factor
with the CVC domain. Chx10 expression, restricted to V2aINs
within the developing spinal cord (Ericson et al., 1997), is induced
ectopically by the misexpression of Lhx3 in the neural tube (Ta-
nabe et al., 1998; Thaler et al., 2002). Chx10 is the best-known
marker of V2aINs. However, the role of Chx10 in V2aIN specifica-
tion and differentiation has not been explored.
In this report, we show that Chx10 promotes V2aIN fate by
actively promoting V2a identity, while simultaneously suppress-
ing non-V2aIN and MN identities. We further show that Chx10
employs two distinct modes of action in promoting V2a fate
and suppressing MN identity. While Chx10 functions as a tran-
scriptional repressor to activate V2aIN program, it acts as a
DNA-binding competitor of the Isl1-Lhx3-complex in suppress-
ing the expression of MN genes. Our findings represent a gener-
alizable phenomenon most likely occurring during the organo-
genesis of many tissues that require segregation of cell fates
derived from related progenitor pools during development.RESULTS
Chx10 Mediates the Activity of Lhx3 in Inducing
V2aIN Fate
To test whether Chx10 contributes to Lhx3-directed induction
of V2aIN identity, we devised a short-hairpin RNA (shRNA)
construct targeting the 30 UTR region of the chick Chx10 tran-
script (Figure 1B). We misexpressed Lhx3 with shRNA-Chx10
or shRNA-vector control in neural progenitors of the developing
spinal cord by using in ovo electroporation and monitored the
formation of ectopic V2aINs 3 days post-electroporation. Co-
electroporation of Lhx3 with shRNA-Chx10 led to a 17.5%
reduction of Chx10+ cells in the electroporated side compared
to the control side (Figures 1B and 1C), confirming effective
knockdown efficiency of shRNA-Chx10. The V2aIN marker
Sox14 expression was induced as soon as V2aINs were born,
and Sox14 was co-expressed with Chx10 in most V2aINs (Fig-
ure S1A). The V2aIN marker Shox2 has been reported to be ex-
pressed in 60% of V2aINs at post-natal day (P)0 (Dougherty
et al., 2013; Joshi et al., 2009; Thaler et al., 2002). We found
that Lhx3 triggers the ectopic expression of Chx10, Sox14,
and Shox2 (Figure 1B). Quantification revealed an increase ofCell Reports 16, 1642–1652, August 9, 2016 1643
Figure 2. Specification of V2aIN Fate
Requires Chx10
(A) Immunohistochemical and in situ hybridization
analyses of E12.5 Chx10orJ/+ and Chx10orJ/orJ lit-
termates. The ventral spinal cords are shown.
Sox14/Lhx3-expressing V2aINs are reduced in
Chx10orJ/orJ spinal cords. While the number of
Hb9+/Isl1+ MNs did not significantly change, Hb9+/
Isl1+MNs emigrate abnormally from the spinal cord
into the motor axonal track outside of the spinal
cord (arrows) in Chx10orJ/orJ mice. The expression
of the cholinergic gene VAChT is also increased in
the ventral spinal cords of Chx10orJ/orJ mice.
(B) Quantification of the number of V2aINs and
MNs in E12.5 mice. The change of the number of
V2aINs and MNs in Chx10orJ/orJ spinal cords is
relative to their control littermates. The error bars
represent the SEM (**p < 0.01; *p < 0.05; non-sig-
nificant, ns; and nR 5 embryos).160%and 106%of Chx10+ and Sox14+ cells, respectively, in the
Lhx3-electroporated spinal cord relative to the unelectroporated
control side (Figure 1C). Lhx3 also induced the expression of ve-
sicular gluatamate transporter 2 (VGluT2), a marker of glutama-
tergic neurons (Figure 1B). Thus, Lhx3 is sufficient to induce
the formation of V2aINs in spinal neural progenitors. With
shRNA-Chx10, however, Lhx3 failed to trigger the expression
of other V2a marker genes, such as Sox14, Shox2, and VGluT2
(Figures 1B and 1C). Lhx3 did not trigger ectopic MN formation
with shRNA-Chx10 or shRNA-vector control (Figure S1B). These
data suggest that Chx10 is a crucial mediator of the activity of
Lhx3 to induce V2aIN fate (Figure 1D).
Development of V2aINs and MNs Is Perturbed in
Chx10-Null Mice
To elucidate the role of Chx10 in the developing spinal cord, we
analyzed Chx10orJ/orJmice (Burmeister et al., 1996). Immunohis-
tochemical analyses with a Chx10 antibody, which detects the
N-terminal region of the mouse Chx10 protein, confirmed that
the expression of Chx10 protein is reduced to undetectable
levels in Chx10orJ/orJ spinal cords (Figures 2A and S2A).
As Chx10 is the best-knownmarker of V2aINs and the produc-
tion of Chx10 transcripts should not be affected by the point mu-
tation in the Chx10orJ allele, we first investigated V2aIN develop-
ment in Chx10orJ/orJ embryos by analyzing the expression level
and pattern of Chx10 transcripts. Chx10 mRNA was markedly
reduced in Chx10orJ/orJ embryos compared to littermate control
Chx10orJ/+ embryos at embryonic day (E)12.5 (Figure 2A), sug-
gesting that V2aIN identity is compromised without Chx10 pro-1644 Cell Reports 16, 1642–1652, August 9, 2016tein. Consistently, the number of Sox14+
and Lhx3+ neurons was reduced by 29%
and 38%, respectively, in Chx10orJ/orJ em-
bryos compared to their control littermates
(Figures 2A, 2B, and S2B). At E12.5, Lhx3
labels both V2aINs and MMCm-type
MNs (Sharma et al., 1998). Double labeling
of Lhx3 and the MN marker Hb9 revealed
that Lhx3+Hb9 V2aINs were substantially
reduced in Chx10orJ/orJ embryos, whereas the number of
Lhx3+Hb9+ MNs did not change (Figures 2B and S2B). Immuno-
staining with activated Caspase 3 antibody showed no substan-
tial change in cell death in Chx10orJ/orJ spinal cords (Figure S2C).
The number of cells expressing Gata3, a V2b interneuron marker,
or Evx1, a V0 interneuron marker, did not change (Figure S2D),
suggesting that the loss of Chx10 did not lead to a fate conversion
to V2b or V0 interneurons. Sox14+ V2aINs remained to be
reduced in E13.5 and E15.5 Chx10orJ/orJ embryos (Figures S2G
and S2H).
In Chx10-deficient mice, several MNs were found in the motor
axonal track outside of the spinal cord (Figures 2A and S2E), indi-
cating that some MN soma abnormally escaped the spinal cord
via the motor exit point in the absence of Chx10. The MNmarker
vesicular acetylcholine transporter (VAChT) was expressedmore
strongly in a wider area in Chx10-null mice than in control litter-
mates (Figures 2A and S2F), suggesting that the VAChT gene be-
comes aberrantly upregulated in Chx10-null neurons.
Overall, our data demonstrate that Chx10 is critical for the
development of V2aINs and that without Chx10, MN gene
expression and development are also perturbed.
Chx10 Triggers V2a Fate, while Suppressing MN Fate,
through Its DNA-Binding Activity
Electroporation of Chx10 alone triggered the formation of
ectopic Sox14+ V2aINs in the developing chick spinal cord (Fig-
ure 3A). While Lhx3 failed to induce V2aINs in MN area, the
expression of Chx10 led to effective generation of V2aINs in
MN area (Figures 1B and 3A). Chx10 also induced the expression
Figure 3. Chx10 Requires Its DNA-Binding
to Promote V2aIN Fate and Suppress MN
Fate
Immunohistochemical and in situ hybridization
analyses in chick spinal cords electroporated (+
side) with Chx10 wild-type (WT) or with a DNA-
binding defective mutant version of Chx10 (Chx10-
N51A) using a panel of V2aIN markers (A) or MN
markers (B) are shown.
(A) Chx10 WT, but not Chx10-N51A, promotes the
expression of V2aIN markers in both dorsal spinal
cord and the MN area (brackets).
(B) Chx10 WT, but not Chx10-N51A, inhibits
specification of MNs.
(C) Quantification of the repression of MN gener-
ation in chick spinal cords electroporated with
Chx10 WT (dark blue bars) or Chx10-N51A (light
blue bars) compared to LacZ-electroporated
control spinal cords. The data are presented as the
percent loss of Hb9+ cells (upper) or Isl1+ cells
(lower). The error bars represent the SEM. The
statistics represent the comparison to LacZ-elec-
troporated spinal cords (***p > 0.005; *p < 0.05;
non-significant, ns; and nR 6 embryos).of Shox2 and VGlut2 in MN area (Figure 3A). These results sug-
gest that Chx10 alone is sufficient to induce V2aIN fate.
To test whether Chx10 converts presumptive MNs to V2aINs,
we examined the generation of MNs in the neural tube electropo-
rated with Chx10. Upon the expression of Chx10, the number of
Hb9+ MNs and Isl1+ MNs decreased by 30% and 46%, respec-
tively (Figures 3B, 3C, and S3). Likewise, the expression of
VAChT, a cholinergic gene, was reduced by Chx10 (Figure 3B).
Thus, Chx10 triggers the generation of V2aINs at the expense
of MNs in the ventral spinal cord.
To test whether the DNA-binding activity of Chx10 is required
to activate V2aIN differentiation and inhibit MN fate, we em-
ployed the DNA-binding defective Chx10-N51A mutant (Dorval
et al., 2005). Despite a high level of expression of Chx10-N51A
comparable to that of Chx10 wild-type, Chx10-N51A neither
induced ectopic V2aINs nor inhibited differentiation of MNs (Fig-
ure 3). These results suggest that binding to Chx10-response el-
ements is required for Chx10 to drive V2aIN fate acquisition and
suppress MN differentiation.
Taken together, our data demonstrate that Chx10 is a critical
and active regulator of V2aIN identity.
Chx10 Effectively Triggers V2a Fate and SuppressesMN
Fate in Differentiating Embryonic Stem Cells
To investigate whether Chx10 can actively promote V2aIN fate
while concomitantly repressing MN identity, we utilized a well-
established differentiation paradigm of mouse embryonic stem
cells (ESCs), which directs ESCs to acquire MN identity (Wich-
terle et al., 2002). To monitor the activity of Chx10 in this context,
we generated doxycycline (Dox)-dependent Chx10-inducible
ESCs (Chx10-ESCs), in which Chx10 coding sequences were in-
serted downstream of the tetracycline response element (TRE)
and the reverse tetracycline transactivator (rtTA) was integrated
into the constitutively active Rosa26 locus (Figure 4A). In Chx10-
ESCs, the expression of FLAG epitope-tagged Chx10 was
robustly induced by Dox treatment (Figure 4B). We differentiatedChx10-ESCs to MNs following the protocol (Wichterle et al.,
2002), in the presence of vehicle or Dox (i.e., Chx10 expression)
(Figures 4A and 4C). Chx10-ESCs differentiated to MNs when
incubated with vehicle, as revealed by strong Hb9-expression
(Figure 4C). However, they failed to differentiate into Hb9+ MNs
when Chx10 expression was induced by Dox (Figure 4C).
Several remaining Hb9+ MNs in the Dox-treated condition ex-
pressed low levels of Chx10 and exhibited a complementary
pattern of expression between Chx10 and Hb9 (Figure 4C).
These results indicate that Chx10 inhibits differentiation of
ESCs to MNs.
To systematically investigate the effect of Chx10 on MN dif-
ferentiation, we performed RNA-sequencing (seq) analyses in
ESC-derived MNs and analyzed the transcriptome changes
triggered by Chx10 expression (i.e., Dox treatment) (Figure 4D;
Table S1). Chx10 led to a significant change in the level of 533
genes (fold change 1.5, p % 0.01). Among these genes, 68%
(363 genes) were downregulated by Chx10, while 32% (170
genes) were upregulated. Many MN genes, such as Hb9, Isl1,
Isl2, choline acetyltransferase (ChAT), and VAChT were sup-
pressed by Chx10. The expression of interneuron genes, such
as Dbx1 and Olig3 that direct V0 and dorsal interneuron dI1-3
fates, respectively, was repressed. Chx10 strongly induced
Sox14, a V2aIN gene, by 149-fold. Other known V2aIN genes,
Sox21 and VGluT2, were also upregulated by Chx10. Chx10-
directed induction of V2aIN genes and repression of MN and
non-V2aIN genes were confirmed by independent qRT-PCR
analyses (Figure 4E). These genome-wide transcriptome ana-
lyses establish that Chx10 can actively promote V2aIN fate,
while suppressing MN development, in the cells that are
directed to acquire MN fate.
Dual Regulatory Modes of Chx10 to Control V2aIN and
MN Fates
Chx10 acts as both transcriptional repressor and activator in
chick neuronal cultures (Dorval et al., 2005). To test whetherCell Reports 16, 1642–1652, August 9, 2016 1645
Figure 4. Chx10 Actively Promotes V2aIN Fate and Suppresses MN Development in Differentiating ESCs
(A) Schematic representation of Chx10-ESCs directed to differentiate into MNs (ESC/MNs) before and after treatment with Dox (TRE and rtTA).
(B) Western analyses show induction of Chx10 after treatment with Dox.
(C) Cell differentiation analyses in Chx10-ESC, directed to differentiate intoMNs, with or without Dox. The upregulation of Chx10 by Dox is correlatedwith a strong
downregulation of the MN marker Hb9.
(D) RNA-seq analyses reveal Chx10-mediated transcriptome changes in ESC-derived MNs. The 533 genes that show a significant change (fold change 1.5,
p% 0.01) are sorted in a heatmap by fold change and biological replicates. The selected genes expressed in MNs and interneurons are highlighted.
(E) The expression levels of selected genes are significantly altered by Chx10 induction in ESC-derived MNs, as obtained with qRT-PCR analyses. y axis shows
log10 values of gene expression levels in Dox-treated MNs relative to vehicle-treated control MNs (Dox). The error bars represent the SD of the mean.Chx10 acts as a transcriptional repressor or activator to drive
V2aIN fate and suppress MN identity, we generated constitu-
tive activator and repressor forms of Chx10 by fusing the
C-terminal half of Chx10, which contains the DNA-binding
HD, to VP16 transcriptional activation domain or Engrailed
transcriptional repression domain (EnR) (Figure 5A). Similarly
to Chx10 wild-type, EnR-Chx10 triggered the formation of
ectopic V2aINs in both dorsal neural tube and MN area, as
indicated by ectopic upregulation of Sox14, Shox2, and
VGluT2 (Figure 5B). However, expression of VP16-Chx10 re-
sulted in a drastic reduction of Sox14+ V2aINs (Figure 5B).
Consistently, expression of VGluT2 and Sox14 was repressed
by VP16-Chx10 (Figure 5B), suggesting that VP16-Chx10
functions as a dominant negative in the V2aIN differentiation
pathway. Therefore, Chx10 functions as a transcriptional
repressor to drive V2a fate specification.
Expression of EnR-Chx10 or VP16-Chx10 led to a decrease of
Hb9+/Isl1+ MNs in chick neural tube (Figure 5B). Similarly, both
fusions reduced VAChT expression (Figure 5B). Therefore,
Chx10 inhibits MN development independently of its transcrip-
tional activity, which is distinct from the requirement of its tran-
scriptional repression activity in promoting V2aIN fate.
Identification of Chx10-Bound Genomic Elements
Our findings suggest that Chx10 suppresses MN genes by
competitively binding to the response elements bound and acti-
vated by MN fate-determining transcription factors such as the
Isl1-Lhx3-complex. Furthermore, the Isl1-Lhx3-binding motif is
similar to the optimal binding site of Chx10, identified in vitro1646 Cell Reports 16, 1642–1652, August 9, 2016(Lee et al., 2008, 2013; Wilson et al., 1993). Thus, Chx10 may
compete with the Isl1-Lhx3-complex to bind to an important
set of MN genes, thereby inhibiting their activation by Isl1-
Lhx3. To test this hypothesis in an unbiased genome-wide
manner, we performed chromatin immunoprecipitation (ChIP)-
seq analyses in Chx10-ESCs and mapped Chx10-binding
genomic loci (Table S2). Among the 363 genes that were down-
regulated by Chx10, 232 genes were associated with Chx10-
bound ChIP-seq peaks (Table S3), suggesting that this set of
genes are likely direct target genes of Chx10. In support of our
hypothesis, these genes included MN genes, including Hb9,
Isl1, ChAT, and VAChT (Table S3). Non-V2aIN genes, such as
Dbx1, Olig3, and Otp also recruited Chx10 (Figure S4; Table
S3) and became downregulated by Chx10 (Figures 4D and 4E),
suggesting that Chx10 represses a subset of non-V2aIN genes
via its repressor activity.
Chx10 also bound the promoter of the Vsx1 gene (Figure S5A).
Chx10 and Vsx1 are the only paired-like HD genes with the CVC
domain in the mouse genome (Chow et al., 2001). Vsx1 is ex-
pressed in differentiating V2 interneurons in zebrafish (Kimura
et al., 2008). Vsx1 displayed similar expression pattern in the
mouse spinal cord, but appeared to be downregulated in more
laterally located, mature Chx10+ V2aINs (Figure S5C). Combined
with our RNA-seq and RT-PCR results that Chx10 represses the
expression of Vsx1 (Figures 4D and S5B), these results suggest
that Chx10 negatively controls Vsx1 transcription in the devel-
oping spinal cord. Interestingly, misexpression of Vsx1 in chick
neural tube results in generation of ectopic Sox14+ cells and in-
hibition of Hb9+ MN formation, resembling the activity of Chx10,
Figure 5. Chx10 Specifies V2a Fate through
Its Transcriptional Repressor Activity and
Inhibits MN Development Independently of
Its Transcriptional Activity
(A) Schematic representation of Chx10 fusions
(EnR, Engrailed repressor domain; VP16, VP16
activator domain; HD, homeodomain).
(B) Immunohistochemical and in situ hybridization
analyses in chick spinal cords electroporated (+
side) with EnR-Chx10 or with VP16-Chx10. EnR-
Chx10 promotes the expression of V2aIN markers
and inhibits MN specification, whereas VP16-
Chx10 inhibits generation of both V2aINs andMNs.
The ectopic V2aINs in the dorsal spinal cord and
the MN area are marked with brackets.although the activity of Vsx1 in inducing ectopic Sox14+ cells
was weaker than that of Chx10 in the dorsal spinal cord (Figures
S5D and 3A). These results indicate the functional redundancy
between Chx10 and Vsx1 in directing V2a specification and in-
hibiting MN differentiation. The redundant action and regulatory
feedback between Chx10 and Vsx1 likely contributes to the gene
network in V2a-MN development.
Next, we compared Chx10-bound ChIP-seq peaks to Isl1-
Lhx3-bound ChIP-seq peaks (Lee et al., 2013) and identified
927 genomic regions that recruit both Chx10 and Isl1-Lhx3 (Fig-
ure 6A; Table S4). To identify DNAmotifs that are significantly en-
riched in this set of ChIP-seq peaks, we analyzed the sequences
of the 927 genomic regions using two complementary motif dis-
covery algorithms, MEME and DREME (Bailey et al., 2009; Ma-
chanick and Bailey, 2011). Both algorithms discovered an almost
identical motif as themost significantly enriched DNA sequences
(Figure 6A). This motif resembles the previously identified bind-
ing sites of Isl1-Lhx3 and Chx10 (Figure 6A) (Lee et al., 2008,
2013; Wilson et al., 1993) and is enriched in the center of the
common peaks for Chx10 and Isl1-Lhx3 (Figure 6B). Thus, this
motif likely serves as a direct binding element for both Chx10
and Isl1-Lhx3.
Overall, we identified a set of direct target genes for Chx10,
which include many known MN genes. Furthermore, these ana-
lyses demonstrate that Chx10 share many genomic target ele-
ments with Isl1-Lhx3.
Chx10 and Isl1-Lhx3 Bind the Same Genomic Regions
Linked to MN Genes
Our studies suggest a model that, during V2aIN differentiation,
Chx10 represses important MN genes by competitively binding
to the response elements that are occupied and activated by
Isl1-Lhx3 in MNs (Figure 7E). To identify the genes that are co-
regulated by Chx10 and Isl1-Lhx3 via the same regulatory ele-
ments, we compared Chx10/Isl1-Lhx3 commonChIP-seq peaks
with two RNA-seq data sets, which identified transcriptome
changes upon expression of Chx10 or Isl1-Lhx3 (Table S1)
(Lee et al., 2012). These analyses revealed 12 genes, which are
associated with Chx10/Isl1-Lhx3-common ChIP-seq peaksand are downregulated by Chx10, while being upregulated by
Isl1-Lhx3 (Figures 6C, 6D, and S6A). These 12 genes have
been implicated in MN development or neuronal functions (see
Discussion).
To further test ourmodel (Figure 7E),we investigated the in vivo
recruitment of Isl1-Lhx3 and Chx10 to their common binding el-
ements inHb9, LMO1, and Slit3/miR218-2 loci. The endogenous
Isl1, Lhx3, and Chx10 proteins were recruited to each of the
common binding sites in the developing spinal cord, as shown
by ChIP in E12.5 mouse spinal cord (Figure 6E). Next, we moni-
tored the binding of Isl1-Lhx3 toHb9, LMO1, and Slit3/miR218-2
loci in the presence of Chx10 wild-type or Chx10-N51A in P19
cells. Chx10 wild-type, but not Chx10-N51A, inhibited the
recruitment of Isl1-Lhx3 to their common binding loci (Fig-
ure S6B). While Hb9 and miR-218 are expressed in MNs and
induced by Isl1-Lhx3 (Tanabe et al., 1998; Thaler et al., 2002;
Thiebes et al., 2015), the regulation of Lmo1 and Slit3 genes in
the neural tube remains unknown. In the developing spinal
cord, the expression of LMO1 and Slit3 were highly and specif-
ically induced as MNs emerged from the progenitor zone (see
unelectroporated control sides in Figure 6F). Interestingly, Isl1-
Lhx3 ectopically upregulated LMO1 and Slit3 in the dorsal spinal
cord, whereas Chx10 inhibited their expression in MNs (Fig-
ure 6F). As expected, both EnR-Chx10 and VP16-Chx10 sup-
pressed LMO1 and Slit3 expression inMNs (Figure 6F). These re-
sults support our model that Chx10 effectively represses MN
genes, at least in part, by competing with Isl1-Lhx3 for the
same response elements (Figure 7E).
To investigate how Chx10 and Isl1-Lhx3 influence the tran-
scriptional activity of their common target genomic elements,
we generated a luciferase reporter linked to a Chx10/Isl1-
Lhx3-bound genomic element upstream of the Lmo1 gene
(Figure 6D). We monitored how the expression of Isl1-Lhx3,
Chx10, or both affects the transcriptional activity of the Lmo1
genomic element using the Lmo1::Luc reporter in P19 mouse
embryonic cells (Figure 6G). While Isl1-Lhx3 potently activated
the Lmo1 element, Chx10 repressed its activity. Furthermore,
Chx10 inhibited Isl1-Lhx3-dependent activation of the reporter
in a DNA-binding activity-dependent manner. VP16-Chx10Cell Reports 16, 1642–1652, August 9, 2016 1647
Figure 6. Chx10 and the Isl1-Lhx3-Complex Bind Common Genomic Regions Linked to MN Genes
(A) Strategy to analyze ChIP-seq data sets for Chx10 and Isl1-Lhx3. The DREME and MEME algorithms identified a nearly identical DNA motif that is enriched in
the 927 common genomic regions recruiting both Chx10 and Isl1-Lhx3. The TOMTOM algorithm demonstrated that this motif resembles Chx10-binding motif in
the database.
(B) Graphical representation of the frequency of the motif from the 927 common ChIP-seq peaks in relation to the central position (0 in x axis) of the peaks.
(C) Fold change of expression for 12 genes associatedwith Chx10/Isl1-Lhx3 commonChIP-seq peaks, which are downregulated byChx10 (blue) in Chx10-ESCs,
while being upregulated by Isl1-Lhx3 (red) in Isl1-Lhx3-ESCs, as obtained with RNA-seq analyses. y axis shows log10 values of gene expression levels in Dox-
treated ESCs relative to vehicle treated controls (Dox).
(D) Overlapping peaks for Isl1-Lhx3 (purple) and Chx10 (green) from ChIP-seq data sets, associated with MN genes Hb9, Lmo1, and Slit3. The peaks are located
upstream of Hb9 and Lmo1 coding regions and intron of the Slit3 gene.
(E) ChIP-qPCR analyses in E12.5mouse spinal cords show that Isl1, Lhx3, and Chx10 are recruited to the ChIP-seq peak regions associatedwithHb9, Lmo1, and
Slit3, but not to the Untr6 gene, a negative control genomic region. The error bars represent the SD (***p < 0.005 and *p < 0.05, compared to IgG).
(F) In situ hybridization analyses in chick spinal cords electroporated (+ side) with Isl1-Lhx3, Chx10, EnR-Chx10, or VP16-Chx10. Isl1-Lhx3 promotes the
expression of Lmo1 and Slit3 in the dorsal spinal cord (bracket), whereas Chx10, EnR-Chx10, and VP16-Chx10 inhibit the expression of LMO1 and Slit3 in MNs.
(G and H) Luciferase assays in P19 cells using luciferase reporters linked to a Chx10/Isl1-Lhx3-bound genomic element upstream of the Lmo1 (G) or Hb9 (H)
genes. Each reporter was co-transfected with constructs shown below the graph. Chx10 WT, but not Chx10 DNA-binding mutant (Chx10 mt and Chx10-N51A),
represses the transcriptional activation of the reporter gene. The error bars represent the SD (***p < 0.005; *p < 0.05; and non-significant, ns).activated the Lmo1::Luc, while EnR-Chx10 suppressed it (Fig-
ure S6C), suggesting that VP16-Chx10 is capable of DNA-bind-
ing and likely functions as DNA-binding competitor of Isl1-Lhx3
in MN inhibition (Figures 5 and 6F). Chx10 acted similarly on
the Hb9::Luc reporter (Figure 6H).
Our data establish that, during V2aIN specification, Chx10 re-
presses a subset of MN genes, which are activated by Isl1-Lhx3
in MNs via shared response elements.1648 Cell Reports 16, 1642–1652, August 9, 2016The Loss of Chx10 Partially Restores the V2aIN-MN
Gene Network Disrupted in Hb9-Null Mice
To further investigate the role of Chx10 in the V2aIN-MN gene
network, we took advantage of the Hb9-null mouse model, in
which MNs are drastically reduced, while Chx10 is aberrantly up-
regulated in the MN area (Figure 7A) (Arber et al., 1999; Thaler
et al., 1999). We hypothesized that the aberrant upregulation
of Chx10 contributes to the reduction of MNs, and it also
Figure 7. Chx10 Is Necessary for the Aberrant Acquisition of V2a Identity in Hb9-Deficient MNs
(A) Immunohistochemical analyses of E12.5 Hb9+/ and Hb9/ littermates. The ventral spinal cords are shown. In Hb9-null spinal cord, Chx10 and Sox14 are
ectopically upregulated in the MN area, while Isl1 expression is markedly reduced.
(B) Quantification of Sox14+ V2aINs and Isl1+ MNs in Hb9 null-spinal cords relative to Hb9+/ control littermates at E12.5. The error bars represent the SEM
(***p < 0.005; n > 3 embryos).
(C) Immunohistochemical analyses of E12.5 Hb9+/;Chx10orJ/+ (dHet) and Hb9/;Chx10orJ/orJ (dKO) littermates. The ventral spinal cords are shown.
(D) Quantification of Sox14+ V2aINs and Isl1+ MNs in dKO spinal cords relative to dHet control littermates at E12.5. The error bars represent the SEM (*p < 0.05;
non-significant, ns; and n > 3 embryos).
(E) In V2aINs, the Lhx3-complex upregulates Chx10 by directly binding the TeRE in the Chx10 gene. Chx10 binds the HxRE associated with MN genes and
represses MN genes. Chx10 also binds and inhibits non-V2aIN genes. In MNs, the Isl1-Lhx3-complex binds and upregulates MN genes.
(F) Gene regulatory mechanisms to precisely establish V2aIN identity, separated from MN or non-V2aIN fate. Lhx3 induces the expression of Chx10. In turn,
Chx10 functions as a transcriptional repressor to activate V2aIN program and to inhibit non-V2aIN genes. Chx10 also functions as a DNA-binding competitor of
the Isl1-Lhx3-complex to suppress MN genes.simultaneously promotes V2aIN genes in Hb9-deficient MNs. To
test this hypothesis, we generated Hb9;Chx10 double knockout
(dKO) mice andmonitored whether the deletion ofChx10 rescues
MN developmental deficits in Hb9-null spinal cords. While Hb9-
null mice showed 54% loss of Isl1+ MNs, Hb9;Chx10 dKO dis-
played 28% reduction of Isl1+ MNs compared to their respective
control littermates (Figures 7A–7D). The Isl1+ MNs in Hb9;Chx10
dKO expressed other MNmarkers, such as Lhx3 and FoxP1 (Fig-
ure S7). Thus, preventing the expression of Chx10 in Hb9-
depleted cells partially restored the compromised MN develop-
ment, indicating that misexpressed Chx10 in Hb9-deficient MNs
is in part responsible for the MN deficits in Hb9-null mice.
To test whether misexpressed Chx10 promotes V2aIN identity
in Hb9-depleted MNs, we performed immunostaining with
Sox14 antibodies. Ectopic Sox14+ cells were found in the ventral
spinal cord of Hb9-null mice, as revealed by 53% increase of
Sox14+ cells (Figures 7A and 7B). Interestingly, however,
Hb9;Chx10 dKO mice showed no significant increase of
Sox14+ cells compared to control littermates (Figures 7C and
7D). These results indicate that the ectopic induction of Chx10
drives the aberrant acquisition of V2a identity in Hb9-null MNs.
DISCUSSION
While the gene regulatory pathway to specify MN fate has been
well characterized (Lee et al., 2008; Lee and Pfaff, 2001), muchless has been known for the transcriptional mechanisms for
specifying V2aINs, whose gene expression profile is related to
that of MNs at progenitor and early differentiation stages.
Despite being the best marker of V2aINs, the actual role of
Chx10 in V2aINs remains unknown. Our analyses of the action
of Chx10 demonstrate that Chx10 plays a crucial role in V2aIN
fate specification and differentiation in the developing spinal
cord. Our comparative genomics analyses, coupled with embry-
onic studies, uncovered how the Chx10-directed V2aIN pathway
interacts with the Isl1-Lhx3-directed MN pathway in the gene
regulatory network of spinal cord development (Figure 7E).
This gene network for V2aINs and MNs provides important in-
sights into a fundamental question in developmental biology;
how two closely related cell fates are specified and maintain
disparate cell identities despite the expression of common tran-
scriptional regulators during organogenesis. Many transcrip-
tional repressors contribute to patterning, cell fate specification,
differentiation, and organogenesis in various developmental
contexts. Thus, the mechanisms by which Chx10 promotes
and consolidates V2aIN fate are applicable to many other devel-
opmental contexts that require the action of transcriptional
repressors.
Our study revealed that the mechanism by which Lhx3 directs
the V2aIN fate is distinct from the mechanism by which Isl1-Lhx3
triggers the MN fate. The Isl1-Lhx3-complex drives MN differen-
tiation by directly binding and inducing a wide range of MNCell Reports 16, 1642–1652, August 9, 2016 1649
genes, whereas the potential of Lhx3 to trigger V2aIN differenti-
ation is mediated largely by its downstream target Chx10, as
demonstrated by our results showing that Lhx3 fails to trigger
V2aIN generation without Chx10 (Figures 1B and 7E). We also
found that Chx10 triggers the formation of ectopic V2aINs
without upregulating Lhx3 in the neural tube (Figure 3A, data
not shown), suggesting that Chx10 does not need Lhx3 to trigger
V2aIN fate. Furthermore, Chx10 is much more effective in
inducing V2aIN fate than Lhx3 in the MN area. Lhx3 is unable
to induce V2aIN genes in the MN domain, most likely due to
the presence of Isl1 and LMO4, which block the formation of
the Lhx3-complex that upregulates Chx10 (Figure 1A) (Lee
et al., 2008; Thaler et al., 2002). However, Chx10 effectively
drives V2aIN differentiation in theMN area (Figure 3A). The ability
of Chx10 to suppress the activity of Isl1-Lhx3most likely enables
Chx10 to effectively convert presumptive MNs into V2aINs.
These findings demonstrate that MNs are inherently capable of
activating V2aIN genes, and this property is unveiled when the
MN program is suppressed by Chx10. Consistently, the V2aIN
program is aberrantly activated in MNs ofHb9-null mice (Figures
7A and 7B). Our analysis of Hb9;Chx10 dKO mice shows that
ectopic induction of V2aIN program in Hb9-null mice is substan-
tially corrected by eliminating Chx10 (Figures 7C and 7D). These
data reinforce the idea that Chx10 is an active driver of V2aIN
fate. They also indicate that the main function of Hb9 with regard
to inhibition of V2aIN fate is to suppress Chx10. Indeed, we have
previously found that Hb9 directly binds and represses Chx10
(Lee et al., 2008).
The action of Chx10 in segregating MN and V2aIN fates is ex-
pected to be particularly important in V2aINs derived from the
progenitor cells located in the boundary between pMN and p2
domains (Figure 7E). The progenitors at the borderline have to
interpret slightly different concentration of Shh and take on either
pMN or p2 identities. Without Chx10, presumptive V2aINs may
upregulate MN genes, but fail to observe MN-periphery bound-
aries and get lost via the motor exit point, contributing to the
reduction of V2aINs.
Our results revealed that Chx10 primarily functions as a tran-
scriptional repressor to induce V2aIN fate, whereas Chx10 in-
hibits MN fate regardless of its inherent transcriptional activity
(Figures 5, 6F, and 7F). Chx10 competes with Isl1-Lhx3 by bind-
ing the shared response elements linked to several MN genes.
Consistently, our comparative ChIP-seq analyses identified
common binding sites for Isl1-Lhx3 and Chx10. Many of these
sites control genes that play a role in MN fate specification, dif-
ferentiation, and function. Hb9, LMO, andmiR-218 are important
to establish MN identity and MN-specific gene expression
pattern (Amin et al., 2015; Arber et al., 1999; Lee et al., 2008;
Thaler et al., 1999; Thiebes et al., 2015). Slit-Robo and sema-
phorin-neuropilin signaling pathways are important for MN cell
body positioning and motor axon guidance (Bai et al., 2011;
Bron et al., 2007; Lee et al., 2015). FGF, NCAM, and NGFR
signaling pathways play a role in MN survival (Garce`s et al.,
2000; Nishimune et al., 2005; Xie et al., 2003). Lix1 is deleted in
autosomal-recessive spinal muscular atrophy, a MN disease
(Fyfe et al., 2006). These findings strongly support our model
that Isl1-Lhx3 and Chx10 commonly target a range of MN genes
and regulate their transcription oppositely (Figure 7E). Given that1650 Cell Reports 16, 1642–1652, August 9, 2016we used stringent cutoff in comparative analyses of two ChIP-
seq and two RNA-seq data sets, the common target MN genes
of Isl1-Lhx3 and Chx10 are likely to be more than the 12 genes
identified in this study.
Chx10 is likely to mobilize transcriptional activators to upregu-
late V2aIN genes, given that it acts as a transcriptional repressor
in directing V2aIN fate. V2aIN-specific transcription factors
downstream of Chx10, such as Sox14may function as activators
to upregulate V2aIN genes, forming a positive feedback loop to
reinforce V2aIN fate choice. Alternatively, a relatively widely ex-
pressed neuronal transcription factor may be responsible for
activating V2aIN genes and Chx10 may be important to sup-
press the inhibitor of this transcriptional activator.
Importantly, our findings represent a generalizable phenome-
non likely occurring during the organogenesis of many different
tissues that require segregation of cell fates derived from closely
related progenitor pools during development.
EXPERIMENTAL PROCEDURES
Mouse Lines
The Chx10orJ/orJ and Hb9/ mutant mice have been previously described
(Burmeister et al., 1996; Thaler et al., 1999). Chx10orJ/orJ mice were obtained
from the Jackson Laboratories. Animals were housed and cared for according
to institutional animal care and use committee guidelines.
Chick in Ovo Electroporation, Immunohistochemistry, and In Situ
Hybridization Assays
In ovo electroporation, immunohistochemistry, and in situ hybridization assays
were performed as previously described on chick or mouse embryos cryosec-
tioned at 13–18 mm (Lee et al., 2004). The following primary antibodies were
used: mouse anti-Hb9/MNR2 (on chick tissue, DSHB, 5C10), rabbit anti-Hb9
(on mouse tissue) (Thaler et al., 1999), rabbit anti-Isl1 (K5) (Tsuchida et al.,
1994), guinea pig anti-Lhx3 (Sharma et al., 1998), guinea pig anti-Chx10 (Lee
et al., 2008; Thaler et al., 1999), rabbit anti-Chx10 (homemade), guinea pig
anti-Sox14 (homemade), rat anti-Gata3 (Absea Biotechnology), rabbit anti-
Evx1 (Moran-Rivard et al., 2001), mouse anti-FLAG (Sigma), and rabbit anti-
activated Caspase 3 (Cell Signaling Technology, #9661). We generated the an-
tibodies against Sox14 and Chx10 using the proteins corresponding to amino
acids 1–154 of mouse Chx10 protein or 67–243 of chick Sox14 (NM_204761).
Culture, Generation, and Differentiation of Chx10-ESCs
Chx10-ESCs were generated from the A172LoxP ESC line (Iacovino et al.,
2011). For MN differentiation assays, Chx10-ESC aggregates (embryoid
bodies, EBs) were treatedwith all trans retinoic acid (0.5 mM) and a Shh agonist
purmorphamine (1 mM; Calbiochem) for 2 days and then cultured with either
Dox (2 mg/ml) or vehicle for additional 2 to 3 days before the analyses.
RT-PCR, RNA-Seq, and ChIP-Seq Assays
Total RNA was extracted using RNeasy Mini Kit (QIAGEN) and reverse tran-
scription was performed using SuperScript III (Invitrogen). RNA-seq libraries
were prepared according to the Illumina TruSeq protocol, validated using
the bioanalyzer and real-time PCR, and then sequenced on the Illumina HiSeq
2000. For ChIP-seq, ChIP DNA samples from Chx10-ESC-derived MNs were
prepared for sequencing according to the Illumina protocol and sequenced on
the Illumina HiSeq 2000. The peak calling was conducted with MACS software
(Zhang et al., 2008). MEME-ChIP Suite (Bailey et al., 2009; Machanick and
Bailey, 2011) and TOMTOM algorithm (Gupta et al., 2007) was used for motif
analysis.
Statistical Analysis
Statistical differences were determined by two-tailed Student’s t test. Statisti-
cal significance is displayed as *p < 0.05, **p < 0.01, *** p < 0.005, and ns (non-
significant).
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